Market Overview

UPDATE: RBC Capital Markets Downgrades LHC Group Ahead of Medicare Home Health Rebasing

Share:
Related LHCG
Why You Should Avoid Envision Healthcare (EVHC) Stock Now
Benzinga's Top Upgrades, Downgrades For March 10, 2017

In a report published Monday, RBC Capital Markets analyst Frank G. Morgan downgraded the rating on LHC Group (NASDAQ: LHCG) from Sector Perform to Underperform, and lowered the price target from $20.00 to $17.00.

In the report, RBC Capital Markets noted, “We do not believe the market is adequately pricing in Home Health earnings downside from the forthcoming rebasing, and we are lowering our outlook for the segment. Note that Home Health stocks are up an average 11.5% since immediately prior to the proposed rule release, including LHCG up 0.8%.”

LHC Group closed on Friday at $22.71.

Latest Ratings for LHCG

DateFirmActionFromTo
Mar 2017RBC CapitalUpgradesSector PerformOutperform
Mar 2017SunTrust Robinson HumphreyUpgradesHoldBuy
Jan 2017BenchmarkInitiates Coverage OnBuy

View More Analyst Ratings for LHCG
View the Latest Analyst Ratings

Posted-In: Frank G. Morgan RBC Capital MarketsAnalyst Color Downgrades Analyst Ratings

 

Related Articles (LHCG)

View Comments and Join the Discussion!